Equity Pricing in the Real World: Moving from Ambiguity to Action for Patients, Payers, and Health Systems Aligning equitable access and commercial sustainability is one of the Read More »
Price Your Asset Right How an analogue analysis supported development of a strategic pricing policy for orphan drugs in low-and middle-income countries Read More
Price Your Asset Right How a rapid four-week evaluation of the commercial viability for a re-purposed orphan drug informed a dynamic due diligence process Read More
Price Your Asset Right How leveraging a ‘glocal’ approach supported the assessment of the pricing and reimbursement potential of a breakthrough orphan drug in China Read More
Price Your Asset Right How a semi-quantitative assessment of achievable pricing, combined with extensive input from global & affiliate colleagues, enabled the refinement of a global pricing strategy leading up to launch Read More
Price Your Asset Right How an innovative pricing calculator enabled the identification of key value drivers and compelling value metrics to support a pricing strategy Read More
Price Your Asset Right How a deep understanding of pricing mechanisms in Japan enabled the formulation of a robust price estimate for a novel radiopharmaceutical Read More
Price Your Asset Right How developing an early payer value story and value messages supported a differentiated offer within neurology, covering multiple possible scenarios at global and regional levels Read More
Price Your Asset Right How the development of an international reference pricing model, supported by a deep understanding of market access dynamics, has supported launch sequencing of two specialty products Read More
Price Your Asset Right How a deep-dive analysis of key analogues facilitated the development of focused recommendations to optimize long-term success for an advanced oncology product facing multiple indication expansions Read More
